vs
GLOBAL INDUSTRIAL Co（GIC）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
GLOBAL INDUSTRIAL Co的季度营收约是Ultragenyx Pharmaceutical Inc.的1.7倍（$345.6M vs $207.3M），GLOBAL INDUSTRIAL Co净利率更高（4.2% vs -62.0%，领先66.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 14.3%），GLOBAL INDUSTRIAL Co自由现金流更多（$19.2M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 3.4%）
Global Industrial公司总部位于纽约州华盛顿港，核心业务是在北美地区通过品牌电商网站及关系营销渠道，向客户供应工业用品及维护、维修与运营（MRO）用品，主品牌为Global Industrial。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
GIC vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $345.6M | $207.3M |
| 净利润 | $14.6M | $-128.6M |
| 毛利率 | 34.5% | — |
| 营业利润率 | 5.7% | -54.7% |
| 净利率 | 4.2% | -62.0% |
| 营收同比 | 14.3% | 25.9% |
| 净利润同比 | 36.4% | 3.5% |
| 每股收益（稀释后） | $0.37 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $345.6M | $207.3M | ||
| Q3 25 | $353.6M | $159.9M | ||
| Q2 25 | $358.9M | $166.5M | ||
| Q1 25 | $321.0M | $139.3M | ||
| Q4 24 | $302.3M | $164.6M | ||
| Q3 24 | $342.4M | $139.5M | ||
| Q2 24 | $347.8M | $147.0M | ||
| Q1 24 | $323.4M | $108.8M |
| Q4 25 | $14.6M | $-128.6M | ||
| Q3 25 | $18.8M | $-180.4M | ||
| Q2 25 | $25.1M | $-115.0M | ||
| Q1 25 | $13.6M | $-151.1M | ||
| Q4 24 | $10.7M | $-133.2M | ||
| Q3 24 | $16.8M | $-133.5M | ||
| Q2 24 | $20.3M | $-131.6M | ||
| Q1 24 | $13.2M | $-170.7M |
| Q4 25 | 34.5% | — | ||
| Q3 25 | 35.6% | — | ||
| Q2 25 | 37.1% | — | ||
| Q1 25 | 34.9% | — | ||
| Q4 24 | 33.8% | — | ||
| Q3 24 | 34.0% | — | ||
| Q2 24 | 35.2% | — | ||
| Q1 24 | 34.3% | — |
| Q4 25 | 5.7% | -54.7% | ||
| Q3 25 | 7.4% | -106.9% | ||
| Q2 25 | 9.3% | -64.8% | ||
| Q1 25 | 5.7% | -102.6% | ||
| Q4 24 | 4.8% | -74.3% | ||
| Q3 24 | 6.5% | -94.6% | ||
| Q2 24 | 7.6% | -79.1% | ||
| Q1 24 | 5.4% | -151.9% |
| Q4 25 | 4.2% | -62.0% | ||
| Q3 25 | 5.3% | -112.8% | ||
| Q2 25 | 7.0% | -69.0% | ||
| Q1 25 | 4.2% | -108.5% | ||
| Q4 24 | 3.5% | -80.9% | ||
| Q3 24 | 4.9% | -95.7% | ||
| Q2 24 | 5.8% | -89.5% | ||
| Q1 24 | 4.1% | -156.8% |
| Q4 25 | $0.37 | $-1.28 | ||
| Q3 25 | $0.48 | $-1.81 | ||
| Q2 25 | $0.65 | $-1.17 | ||
| Q1 25 | $0.35 | $-1.57 | ||
| Q4 24 | $0.28 | $-1.34 | ||
| Q3 24 | $0.44 | $-1.40 | ||
| Q2 24 | $0.52 | $-1.52 | ||
| Q1 24 | $0.34 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $67.5M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $313.2M | $-80.0M |
| 总资产 | $580.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $67.5M | $421.0M | ||
| Q3 25 | $67.2M | $202.5M | ||
| Q2 25 | $55.1M | $176.3M | ||
| Q1 25 | $39.0M | $127.1M | ||
| Q4 24 | $44.6M | $174.0M | ||
| Q3 24 | $38.9M | $150.6M | ||
| Q2 24 | $38.8M | $480.7M | ||
| Q1 24 | $29.9M | $112.3M |
| Q4 25 | $313.2M | $-80.0M | ||
| Q3 25 | $316.0M | $9.2M | ||
| Q2 25 | $305.2M | $151.3M | ||
| Q1 25 | $287.9M | $144.2M | ||
| Q4 24 | $281.1M | $255.0M | ||
| Q3 24 | $279.2M | $346.8M | ||
| Q2 24 | $270.4M | $432.4M | ||
| Q1 24 | $260.2M | $140.3M |
| Q4 25 | $580.8M | $1.5B | ||
| Q3 25 | $602.5M | $1.2B | ||
| Q2 25 | $586.5M | $1.3B | ||
| Q1 25 | $536.7M | $1.3B | ||
| Q4 24 | $520.7M | $1.5B | ||
| Q3 24 | $531.6M | $1.5B | ||
| Q2 24 | $542.5M | $1.6B | ||
| Q1 24 | $517.4M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.0M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $19.2M | $-100.8M |
| 自由现金流率自由现金流/营收 | 5.6% | -48.6% |
| 资本支出强度资本支出/营收 | 0.2% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.37× | — |
| 过去12个月自由现金流最近4个季度 | $74.7M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $20.0M | $-99.8M | ||
| Q3 25 | $22.7M | $-91.4M | ||
| Q2 25 | $31.7M | $-108.3M | ||
| Q1 25 | $3.4M | $-166.5M | ||
| Q4 24 | $15.9M | $-79.3M | ||
| Q3 24 | $9.6M | $-67.0M | ||
| Q2 24 | $18.8M | $-77.0M | ||
| Q1 24 | $6.4M | $-190.7M |
| Q4 25 | $19.2M | $-100.8M | ||
| Q3 25 | $22.0M | $-92.7M | ||
| Q2 25 | $30.3M | $-110.7M | ||
| Q1 25 | $3.2M | $-167.8M | ||
| Q4 24 | $15.2M | $-79.5M | ||
| Q3 24 | $8.7M | $-68.6M | ||
| Q2 24 | $17.9M | $-79.0M | ||
| Q1 24 | $5.1M | $-193.9M |
| Q4 25 | 5.6% | -48.6% | ||
| Q3 25 | 6.2% | -58.0% | ||
| Q2 25 | 8.4% | -66.5% | ||
| Q1 25 | 1.0% | -120.5% | ||
| Q4 24 | 5.0% | -48.3% | ||
| Q3 24 | 2.5% | -49.2% | ||
| Q2 24 | 5.1% | -53.7% | ||
| Q1 24 | 1.6% | -178.2% |
| Q4 25 | 0.2% | 0.5% | ||
| Q3 25 | 0.2% | 0.8% | ||
| Q2 25 | 0.4% | 1.5% | ||
| Q1 25 | 0.1% | 1.0% | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 0.3% | 1.2% | ||
| Q2 24 | 0.3% | 1.4% | ||
| Q1 24 | 0.4% | 3.0% |
| Q4 25 | 1.37× | — | ||
| Q3 25 | 1.21× | — | ||
| Q2 25 | 1.26× | — | ||
| Q1 25 | 0.25× | — | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 0.48× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GIC
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
